Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07799675 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Telerehabilitation in Pulmonary Arterial Hypertension

Study acronym: TRHP-001
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-08-30
View on ClinicalTrials.gov ↗
Context: Pulmonary arterial hypertension (PAH) causes severe exercise intolerance and reduced quality of life, while access to supervised rehabilitation remains limited. Objective: Evaluate the safety, feasibility, and clinical effects of an 8-week structured home-based telerehabilitation program in stable PAH patients. Methods: A multicenter, prospective, single-arm study including 34 adults with Group 1 PAH (WHO functional class II-III) performing three weekly exercise sessions via a digital platform. Outcomes: The primary endpoint is peak oxygen consumption (VO₂peak) via cardiopulmonary exercise testing, alongside 6-minute walk distance, quality of life questionnaires, inflammatory biomarkers, and safety tracking.
Trial Details
NCT Number NCT07799675
Lead Sponsor Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Conditions Pulmonary Arterial Hypertension (PAH)
Enrollment 34 participants
Start Date 2026-08-30
Primary Completion 2029-07-01 (estimated)
Study Completion 2029-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-02